2018
DOI: 10.1111/aos.13676
|View full text |Cite
|
Sign up to set email alerts
|

ATP‐binding cassette subfamily A, member 4 intronic variants c.4773+3A>G and c.5461‐10T>C cause Stargardt disease due to defective splicing

Abstract: Two intronic variants c.4773+3A>G and c.5461-10T>C, both predicted to affect splicing, are indeed disease-causing mutations due to skipping of exons 33, 34, 39 and 40 of ABCA4 gene. The experimental proof that ABCA4 mutations in STGD patients affect protein function is crucial for their inclusion to future clinical trials; therefore, functional testing of all ABCA4 intronic variants associated with Stargardt disease by minigene technology is desirable.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 34 publications
1
14
0
Order By: Relevance
“…The most readily available method to assess variants involves use of plasmid transfection to recapitulate the patient’s mutation in mammalian cells. Minigene and Midigene constructs incorporating exons and introns for the IRD gene and including the candidate splice mutation have been hugely successful in providing empirical evidence of the functional effect of candidate splice variants [ 150 , 151 , 152 , 153 ]. Patient-derived cell and/or 3D retinal organoid models while more laborious to create, remove the need for transient expression of mutations as the mutation is already present in the patient’s cells.…”
Section: Modifiers Of Ird Phenotypesmentioning
confidence: 99%
“…The most readily available method to assess variants involves use of plasmid transfection to recapitulate the patient’s mutation in mammalian cells. Minigene and Midigene constructs incorporating exons and introns for the IRD gene and including the candidate splice mutation have been hugely successful in providing empirical evidence of the functional effect of candidate splice variants [ 150 , 151 , 152 , 153 ]. Patient-derived cell and/or 3D retinal organoid models while more laborious to create, remove the need for transient expression of mutations as the mutation is already present in the patient’s cells.…”
Section: Modifiers Of Ird Phenotypesmentioning
confidence: 99%
“…It was first discovered in 1999 in Stargardt disease patients (Maugeri et al, 1999), and has been described as the third most frequent gene variant associated with Stargardt disease in individuals with European or African descent (Zernant et al, 2011;Roberts et al, 2012;Miraldi Utz et al, 2014). Although it was initially identified as a sequence variant without significant functional consequence (Rivera et al, 2000), recent reports suggest that this mutation results in a decreased expression level of wild type ABCA4 and splicing defects with exons 39/40 skipped, leading to frameshift and premature stop, playing a causative and a pathological role in Stargardt disease (Sangermano et al, 2016;Aukrust et al, 2017;Jonsson et al, 2018). We predict that the intronic mutation, c.5461-10T > C in ABCA4, contributes to the Stargardt disease in Family 4100.…”
Section: Discussionmentioning
confidence: 99%
“…Missense variants are usually caused by a single nucleotide change, which usually results in a change in the amino acid. The consequences of this are difficult to predict as not all amino acid changes lead to changes in the protein structure that result in a change in function [54,105,106]. Many of these missense variants are rare, which further complicates determining their severity and whether they are truly pathogenic [20,107,108].…”
Section: Spectrum Of Pathogenic Variants In Abca4mentioning
confidence: 99%